Liver Resection for Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma

被引:51
|
作者
Koh, Ye Xin [1 ]
Tan, Hiang Jin [1 ]
Liew, Yi Xin [2 ]
Syn, Nicholas [1 ]
Teo, Jin Yao [1 ,4 ]
Lee, Ser Yee [1 ,4 ]
Goh, Brian K. P. [1 ,4 ]
Goh, George B. B. [3 ,4 ]
Chan, Chung Yip [1 ,4 ]
机构
[1] Singapore Gen Hosp, Dept Hepatopancreatobiliary & Transplant Surg, 20 Coll Rd, Singapore 169856, Singapore
[2] Singapore Gen Hosp, Dept Pharm, Singapore, Singapore
[3] Singapore Gen Hosp, Dept Gastroenterol & Hepatol, Singapore, Singapore
[4] Duke Natl Univ Singapore, Singapore, Singapore
关键词
NAFLD; STEATOHEPATITIS; SURVIVAL;
D O I
10.1016/j.jamcollsurg.2019.07.012
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD)-related hepatocellular carcinoma (HCC) is on the rise worldwide, but data on long-term outcomes after curative operations are limited. The primary aim of this study was to characterize the perioperative and long-term outcomes after liver resection. The secondary aim was to investigate the influence of the histologic severity of nonalcoholic steatohepatitis and its impact on perioperative outcomes and long-term survival. METHODS: A total of 996 patients who underwent liver resection for HCC in our institution were analyzed. Patients were categorized into subgroups of NAFLD vs non-NAFLD HCC based on histologic evidence of hepatic steatosis. Comparisons of patients' demographic, clinical, and surgical characteristics; postoperative complications; and survival outcomes were performed. RESULTS: Eight hundred and forty-four patients had non-NAFLD HCC and 152 patients had NAFLD HCC. Comorbidities were significantly more common in the NAFLD group (p < 0.0001). In the non-NAFLD group, larger median tumor size, higher liver cirrhosis, and lower median neutrophil to lymphocyte ratio were observed (p < 0.0001). The NAFLD group had a greater amount of intraoperative blood loss, more postoperative complications, and longer length of stay. Five-year overall survival was significantly better in the NAFLD group (p = 0.0355). Significant factors that contribute to poorer survival outcomes include age, congestive cardiac failure, Child-Pugh's class B, cirrhosis, tumor size, multinodularity, and R1 resection. For NAFLD group, patients with abnormal parenchyma showed poorer survival and 5-year overall survival rates (64.8% vs 75.6%; p = 0.2291). CONCLUSIONS: Nonalcoholic fatty liver disease-related HCC is associated with greater surgical morbidity and post-hepatectomy liver failure. Despite this, long-term survival outcomes are favorable compared with non-NAFLD etiologies. ((C) 2019 by the American College of Surgeons. Published by Elsevier Inc. All rights reserved.)
引用
收藏
页码:467 / +
页数:13
相关论文
共 50 条
  • [41] Hepatocellular Carcinoma Screening and Nonalcoholic Fatty Liver Disease: How is it Different?
    Acharya, Subrat K.
    Bopanna, Sawan
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2020, 10 (05) : 518 - 524
  • [42] From Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma: A Systems Understanding
    Damjana Rozman
    Digestive Diseases and Sciences, 2014, 59 : 238 - 241
  • [43] Clinicopathological features of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease
    Yoshihiro Mikuriya
    Hirotaka Tashiro
    Tsuyoshi Kobayashi
    Shintaro Kuroda
    Tomoyuki Abe
    Masakazu Hashimoto
    Hideki Ohdan
    Langenbeck's Archives of Surgery, 2015, 400 : 471 - 476
  • [44] Nonalcoholic fatty liver disease (NAFLD) and hepatocellular carcinoma: How common?
    Mittal S.
    White D.L.
    Kanwal F.
    Sussman N.
    El-Serag H.B.
    Current Hepatology Reports, 2015, 14 (2) : 87 - 98
  • [45] Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans Is Associated With Nonalcoholic Fatty Liver Disease
    Mittal, Sahil
    El-Serag, Hashem B.
    Sada, Yvonne H.
    Kanwal, Fasiha
    Duan, Zhigang
    Temple, Sarah
    May, Sarah B.
    Kramer, Jennifer R.
    Richardson, Peter A.
    Davila, Jessica A.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (01) : 124 - +
  • [46] Diabetic Retinopathy as a Risk Factor Associated with the Development of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
    Azuma, Seishin
    Asahina, Yasuhiro
    Kakinuma, Sei
    Azuma, Keiko
    Miyoshi, Masato
    Inoue, Emi
    Tsunoda, Tomoyuki
    Sato, Ayako
    Kaneko, Shun
    Nagata, Hiroko
    Kawai-Kitahata, Fukiko
    Murakawa, Miyako
    Nitta, Sayuri
    Itsui, Yasuhiro
    Tomita, Makoto
    Nakagawa, Mina
    Watanabe, Mamoru
    DIGESTIVE DISEASES, 2019, 37 (03) : 247 - 254
  • [47] Improved survival after treatments of patients with nonalcoholic fatty liver disease associated hepatocellular carcinoma
    Benhammou, Jihane N.
    Aby, Elizabeth S.
    Shirvanian, Gayaneh
    Manansala, Kohlett
    Hussain, Shehnaz K.
    Tong, Myron J.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [48] Clinical features of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: a review of human studies
    Oda K.
    Uto H.
    Mawatari S.
    Ido A.
    Clinical Journal of Gastroenterology, 2015, 8 (1) : 1 - 9
  • [49] Improved survival after treatments of patients with nonalcoholic fatty liver disease associated hepatocellular carcinoma
    Jihane N. Benhammou
    Elizabeth S. Aby
    Gayaneh Shirvanian
    Kohlett Manansala
    Shehnaz K. Hussain
    Myron J. Tong
    Scientific Reports, 10
  • [50] Nonalcoholic Fatty Liver Disease-Related Cirrhosis Is Commonly Unrecognized and Associated With Hepatocellular Carcinoma
    Bertot, Luis C.
    Jeffrey, Gary P.
    Wallace, Michael
    MacQuillan, Gerry
    Garas, George
    Ching, Helena L.
    Adams, Leon A.
    HEPATOLOGY COMMUNICATIONS, 2017, 1 (01) : 53 - 60